Is urokinase gene 3'-UTR polymorphism associated with prostate cancer?

Cancer Biomarkers

Volumn 1, Issue 6, 2005, Pages 287-292

  Mittal, Rama Devi ^a   Srivastava, Daya Shankar Lal ^a   Mishra, Dhruva K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

polymerase chain reaction (PCR); prostate cancer (CaP); restriction fragment length polymorphism (RFLP); Urokinase

Indexed keywords

UROKINASE;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PROSTATE TUMOR;

3' UNTRANSLATED REGIONS; ADULT; AGED; AGED, 80 AND OVER; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; URINARY PLASMINOGEN ACTIVATOR;

EID: 39049182978     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2005-1604     Document Type: Article

References (22)

1. B.S. Carter, T.H. Beaty, G.D. Steinberg, B. Childs and P.C. Walsh, Mendelian inheritance of familial prostate cancer, Proc. Natl. Acad. Sci. USA. 89 (1992), 3367-3371.
2. C. Chen, Risk of prostate cancer in relation to polymorphisms of metabolic genes, Epidemiol. Rev. 23 (2001), 30-35.
3. H.T. Chou, Y.T. Chen, J.Y. Wu and F.J. Tsai, Association between urokinase-plasminogen activator gene T4065C polymorphism and risk of mitral valve prolapse, Int. J. Cardiol. 96 (2004), 165-170.
4. B. Conne, M. Berczy and D. Belin, Detection of polymorphisms in the human urokinase-type plasminogen activator gene, Thromb. Haemost. 77 (1997), 434-435.
5. B.R. Das and J.K. Nagpal, Understanding the biology of oral cancer, Med. Sci. Monit. 8 (2002), RA258-RA267.
6. F.D. Gaylis, H.N. Keer, M.J.Wilson, H.C. Kwaan, A.A. Sinha and J.M.Kozlowski, Plasminogen activators in human prostate cancer cell lines and tumors: correlation with the aggressive phenotype, J. Urol. 142 (1989), 193-198.
7. M.A. Helenius, O.R. Saramaki, M.J. Linja, T.L. Tammela and T. Visakorpi, Amplification of urokinase gene in prostate cancer, Cancer Res 61 (2001), 5340-5344.
8. C.-H.C.W.-C.C.H.-Y.C.a.F.-J.T. Hsi-Chin Wu, Urokinase gene 3'-UTR T/C polymorphism is not associated with bladder cancer, Genetics and Molecular Biology 27 (2004), 15-16.
9. P. Lichtenstein, N.V. Holm, P.K. Verkasalo, A. Iliadou, J. Kaprio, M. Koskenvuo, E. Pukkala, A. Skytthe and K. Hemminki, Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland, N. Engl. J. Med. 343 (2000), 78-85.
10. M.P. Look and J.A. Foekens, Clinical relevance of the urokinase plasminogen activator system in breast cancer, APMIS 107 (1999), 150-159.
11. S.A. Miller, D.D. Dykes and H.F. Polesky, A simple salting out procedure for extracting DNAfrom human nucleated cells, Nucleic Acids Res 16 (1988), 1215.
12. D. Mishra, K. Thangaraj, A. Mandhani, A. Kumar and R. Mittal, Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Clin. Genet. 68 (2005), 55-60.
13. D.K. Mishra, H.K. Bid, D.S. Srivastava, A. Mandhani and R.D. Mittal, Association of vitamin D receptor gene polymorphism and risk of prostate cancer in India, Urol. Int. 74 (2005), 315-318.
14. R.D. Mittal, D.S. Srivastava, A. Mandhani, A. Kumar and B. Mittal, Polymorphism of GSTM1 and GSTT1 genes in prostate cancer: a study from North India, Indian J. Cancer. 41 (2004), 115-119.
15. K. Przybylowska, K. Smolarczyk, J. Blasiak, A. Kulig, H. Romanowicz-Makowska, A. Dziki, J. Ulanska and B. Pander, A C/T polymorphism in the urokinase-type plasminogen activator gene in colorectal cancer, J. Exp. Clin. Cancer Res. 20 (2001), 569-572.
16. K. Przybylowska, K. Smolarczyk, J. Blasiak, A. Kulig, H. Romanowicz-Makowska, A. Dziki, J. Ulanska and B. Pander, A C/T polymorphism in the urokinase-type plasminogen activator gene in colorectal cancer, J. Exp. Clin. Cancer Res. 20 (2001), 569-572.
17. C. Pyke, P. Kristensen, E. Ralfkiaer, J. Grondahl-Hansen, J. Eriksen, F. Blasi and K. Dano, Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas, Am. J. Pathol. 138 (1991), 1059-1067.
18. R. Sinha, D.E. Anderson, S.S. McDonald and P. Greenwald, Cancer risk and diet in India, J. Postgrad. Med. 49 (2003), 222-228.
19. L. Skriver, L.I. Larsson, V. Kielberg, L.S. Nielsen, P.B. Andresen, P. Kristensen and K. Dano, Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma, J. Cell Biol. 99 (1984), 752-757.
20. D.S. Srivastava, A. Mandhani, B. Mittal and R.D. Mittal, Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India, BJU. Int. 95 (2005), 170-173.
21. M.H. Tsai, W.C. Chen, H.Y. Chen and F.J. Tsai, Urokinase gene 3'-UTR T/C polymorphism is associated with oral cancer, J. Clin. Lab Anal. 18 (2004), 276-279.
22. M.H. Tsai, W.C. Chen, H.Y. Chen and F.J. Tsai, Urokinase gene 3'-UTR T/C polymorphism is associated with oral cancer, J. Clin. Lab Anal. 18 (2004), 276-279.